[EN] COMPOUNDS FOR TREATING POLYQ-RELATED NEURODEGENERATIVE DISORDERS<br/>[FR] COMPOSÉS POUR LE TRAITEMENT DE TROUBLES NEURODÉGÉNÉRATIFS ASSOCIÉS À LA POLYQ
申请人:[en]HANGZHOU JIJING PHARMACEUTICAL TECHNOLOGY LIMITED
公开号:WO2023104170A1
公开(公告)日:2023-06-15
One embodiment of the disclosure is a compound represented by Formula (I) or a pharmaceutically acceptable salt thereof. The variables in Formula (I) are defined herein. Compounds of Formula (I) can be used to treat polyQ-related neurodegenerative disorders.